These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 39087462

  • 21. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients.
    Florman S, Alloway R, Kalayoglu M, Punch J, Bak T, Melancon J, Klintmalm G, Busque S, Charlton M, Lake J, Dhadda S, Wisemandle K, Wirth M, Fitzsimmons W, Holman J, First MR.
    Transplantation; 2007 Jun 27; 83(12):1639-42. PubMed ID: 17589349
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study.
    Sánchez Fructuoso A, Ruiz JC, Franco A, Diekmann F, Redondo D, Calviño J, Serra N, Aladrén MJ, Cigarrán S, Manonelles A, Ramos A, Gómez G, González Posada JM, Andrés A, Beneyto I, Muñiz AL, Perelló M, Lauzurica R.
    Clin Transplant; 2020 Jan 27; 34(1):e13767. PubMed ID: 31815310
    [Abstract] [Full Text] [Related]

  • 23. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
    An S, Lee S, Rhu J, Kim JM, Choi GS, Joh JW.
    J Pediatr Surg; 2023 Oct 27; 58(10):2054-2058. PubMed ID: 37277238
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tacrolimus Intrapatient Variability on Graft Outcomes in Adherent Renal Transplantation Patients: A Cross-Sectional Study.
    Nafar M, Keshtkari S, Ziaie S, Firouzan A, Borumandnia N, Dalili N, Poorrezagholi F, Samadian F, Samavat S.
    Iran J Kidney Dis; 2024 May 27; 18(3):187-194. PubMed ID: 38904339
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
    Altieri M, Delaval G, Kimmoun E, Allaire M, Salamé E, Dumortier J.
    Exp Clin Transplant; 2018 Jun 27; 16(3):321-325. PubMed ID: 28697715
    [Abstract] [Full Text] [Related]

  • 30. Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.
    Seibert SR, Schladt DP, Wu B, Guan W, Dorr C, Remmel RP, Matas AJ, Mannon RB, Israni AK, Oetting WS, Jacobson PA.
    Clin Transplant; 2018 Dec 27; 32(12):e13424. PubMed ID: 30318646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The effect of transfer to adult transplant care on kidney function and immunosuppressant drug level variability in pediatric kidney transplant recipients.
    Fernandez HE, Amaral S, Shaw PA, Doyle AM, Bloom RD, Palmer JA, Baluarte HJ, Furth SL.
    Pediatr Transplant; 2019 Sep 27; 23(6):e13527. PubMed ID: 31209988
    [Abstract] [Full Text] [Related]

  • 34. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial.
    Plischke M, Riegersperger M, Dunkler D, Heinze G, Kikić Ž, Winkelmayer WC, Sunder-Plassmann G.
    PLoS One; 2015 Sep 27; 10(8):e0135674. PubMed ID: 26270340
    [Abstract] [Full Text] [Related]

  • 35. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden.
    Fellström B, Holmdahl J, Sundvall N, Cockburn E, Kilany S, Wennberg L.
    Transplant Proc; 2018 Dec 27; 50(10):3275-3282. PubMed ID: 30577197
    [Abstract] [Full Text] [Related]

  • 36. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients.
    Maurer MM, Ibach M, Plewe J, Winter A, Ritschl P, Globke B, Öllinger R, Lurje G, Schöning W, Pratschke J, Eurich D.
    Biomedicines; 2022 Jan 26; 10(2):. PubMed ID: 35203481
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimus.
    Vondrak K, Parisi F, Dhawan A, Grenda R, Webb NJA, Marks SD, Debray D, Holt RCL, Lachaux A, Kelly D, Kazeem G, Undre N.
    Clin Transplant; 2019 Oct 26; 33(10):e13698. PubMed ID: 31436896
    [Abstract] [Full Text] [Related]

  • 40. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
    Naicker D, Reed PW, Ronaldson J, Kara T, Wong W, Prestidge C.
    Pediatr Nephrol; 2017 Nov 26; 32(11):2125-2131. PubMed ID: 28660366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.